Gruber-Wackernagel A - Search Results

1

Accumulation of Cytotoxic Skin Resident Memory T Cells and Increased Expression of IL-15 in Lesional Skin of Polymorphic Light Eruption.

Patra V, Strobl J, Atzmüller D, Reininger B, Kleissl L, Gruber-Wackernagel A, Nicolas JF, Stary G, Vocanson M, Wolf P. Patra V, et al. Among authors: gruber wackernagel a. Front Med (Lausanne). 2022 Jun 10;9:908047. doi: 10.3389/fmed.2022.908047. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35755042 Free PMC article.

2

New insights into the mechanisms of polymorphic light eruption: resistance to ultraviolet radiation-induced immune suppression as an aetiological factor.

Wolf P, Byrne SN, Gruber-Wackernagel A. Wolf P, et al. Exp Dermatol. 2009 Apr;18(4):350- 6. doi: 10.1111/j.1600-0625.2009.00859.x. Exp Dermatol. 2009. PMID: 19348001

3

Pathogenic mechanisms of polymorphic light eruption.

Gruber-Wackernagel A, Byrne SN, Wolf P. Gruber-Wackernagel A, et al. Front Biosci (Elite Ed). 2009 Jun 1;1(1):341-54. doi: 10.2741/E33. Front Biosci (Elite Ed). 2009. PMID: 19482651 Free article. Review.

4

Photohardening restores the impaired neutrophil responsiveness to chemoattractants leukotriene B4 and formyl-methionyl-leucyl-phenylalanin in patients with polymorphic light eruption.

Gruber-Wackernagel A, Heinemann A, Konya V, Byrne SN, Singh TP, Hofer A, Legat F, Wolf P. Gruber-Wackernagel A, et al. Exp Dermatol. 2011 Jun;20(6):473-6. doi: 10.1111/j.1600-0625.2011.01264.x. Epub 2011 Mar 16. Exp Dermatol. 2011. PMID: 21410775

5

Randomized double-blinded placebo-controlled intra-individual trial on topical treatment with a 1,25-dihydroxyvitamin D₃ analogue in polymorphic light eruption.

Gruber-Wackernagel A, Bambach I, Legat FJ, Hofer A, Byrne SN, Quehenberger F, Wolf P. Gruber-Wackernagel A, et al. Br J Dermatol. 2011 Jul;165(1):152-63. doi: 10.1111/j.1365-2133.2011.10333.x. Epub 2011 May 30. Br J Dermatol. 2011. PMID: 21428979 Clinical Trial.

6

Topical liposomal DNA-repair enzymes in polymorphic light eruption.

Hofer A, Legat FJ, Gruber-Wackernagel A, Quehenberger F, Wolf P. Hofer A, et al. Photochem Photobiol Sci. 2011 Jul;10(7):1118-28. doi: 10.1039/c1pp05009e. Epub 2011 Mar 24. Photochem Photobiol Sci. 2011. PMID: 21437317 Clinical Trial.

7

311 nm ultraviolet B-accelerated response of psoriatic lesions in adalimumab-treated patients.

Wolf P, Hofer A, Weger W, Posch-Fabian T, Gruber-Wackernagel A, Legat FJ. Wolf P, et al. Photodermatol Photoimmunol Photomed. 2011 Aug;27(4):186-9. doi: 10.1111/j.1600-0781.2011.00594.x. Photodermatol Photoimmunol Photomed. 2011. PMID: 21729166 Clinical Trial.

8

Phototherapeutic hardening modulates systemic cytokine levels in patients with polymorphic light eruption.

Wolf P, Gruber-Wackernagel A, Rinner B, Griesbacher A, Eberhard K, Groselj-Strele A, Mayer G, Stauber RE, Byrne SN. Wolf P, et al. Photochem Photobiol Sci. 2013 Jan;12(1):166-73. doi: 10.1039/c2pp25187f. Photochem Photobiol Sci. 2013. PMID: 22949107 Clinical Trial.

9

Patients with polymorphic light eruption have decreased serum levels of 25-hydroxyvitamin-D3 that increase upon 311 nm UVB photohardening.

Gruber-Wackernagel A, Obermayer-Pietsch B, Byrne SN, Wolf P. Gruber-Wackernagel A, et al. Photochem Photobiol Sci. 2012 Dec;11(12):1831-6. doi: 10.1039/c2pp25188d. Photochem Photobiol Sci. 2012. PMID: 22952008 Clinical Trial.

10

Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis.

Singh TP, Schön MP, Wallbrecht K, Gruber-Wackernagel A, Wang XJ, Wolf P. Singh TP, et al. PLoS One. 2013;8(1):e51752. doi: 10.1371/journal.pone.0051752. Epub 2013 Jan 15. PLoS One. 2013. PMID: 23335955 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page